Advertisement

Setting up and implementing blood donor discharge guideline

      The donor vigilance process is one of the most important steps in the recruitment and retention of blood donors [
      • Wiersum-Osselton J.C.
      • Marijt-van der Kreek T.
      • de Kort W.L.
      Donor vigilance: what are we doing about it?.
      ,
      • Burkhardt T.
      • Dimanski B.
      • Karl R.
      • Sievert U.
      • Karl A.
      • Hübler C.
      • et al.
      Donor vigilance data of a blood transfusion service: a multicenter analysis.
      ]. Immediate and delayed reactions to blood donation are the main complications that lead to donor dissatisfaction and in some situations cause legal problems for blood transfusion organizations. Since 2019, in the Iranian Blood Transfusion Organization, the discharge process has been set up and optimized through: 1- checking the vital sign and general appearance of donors when leaving the donation centers and 2- identifying donation reactions in the early stages and reducing the event occurrence, severity, and consequences. The purpose of this process is to reduce the number of reactions after leaving the blood donation center and increase donor satisfaction by ensuring the organization's commitment to their health.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wiersum-Osselton J.C.
        • Marijt-van der Kreek T.
        • de Kort W.L.
        Donor vigilance: what are we doing about it?.
        Biologicals. 2012; 40: 176-179
        • Burkhardt T.
        • Dimanski B.
        • Karl R.
        • Sievert U.
        • Karl A.
        • Hübler C.
        • et al.
        Donor vigilance data of a blood transfusion service: a multicenter analysis.
        Transfus Apher Sci. 2015 1; 53: 180-184
        • Mikkelsen C.
        • Paarup H.M.
        • Bruun M.T.
        • Pedersen L.Ø.
        • Hasslund S.
        • Larsen R.
        • et al.
        The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration.
        Vox Sang. 2021;
        • Bisht A.
        • Marwaha N.
        • Arora S.
        • Patidar G.K.
        • Chhabra R.
        National blood donor vigilance program of India: analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017).
        Asian J Transfus Sci. 2021; 15: 1
        • Stefano Orru K.P.
        • Hoffelner M.
        • Heiden M.
        • Funk M.B.
        • Keller-Stanislawski B.
        • Oberle D.
        Blood donation-related adverse reactions: results of an online survey among donors in Germany (2018).
        Transfus Med Hemotherapy. 2021; 48: 272